{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:961",
      "entity_text" : "OH",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ10265",
      "entity_text" : "SB225002",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Likewise, co-treatment with the CXCR1/2 inhibitor SB225002 reduced the overall response of HSPCs to 1,25 (OH) D3 stimulation, as determined by WISH (XREF_SUPPLEMENTARY) and FACS (XREF_SUPPLEMENTARY) (con versus 1,25 (OH) D3, p < 0.01; 1,25 (OH) D3 versus SB25002, p < 0.01; con versus 1,25 (OH) D3 + SB25002, N.S.; 1,25 (OH) D3 versus 1,25 (OH) D3 + SB25002, N.S.",
  "reading_complete" : "2020-08-08T13:41:12Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T13:38:11Z",
  "trigger" : "reduced",
  "evidence" : [ "SB225002               reduced the overall response of HSPCs to 1,25(OH" ],
  "pmc_id" : "5338633",
  "score" : 0
}